Company Filing History:
Years Active: 2022
Title: Mark Bodmer: Innovator in Immune Modulation
Introduction
Mark Bodmer is a notable inventor based in Boston, MA, who has made significant contributions to the field of immune disorders. His work focuses on developing therapeutic agents that utilize immune-modulating bacteria strains. With a keen interest in advancing medical science, Bodmer has secured a patent that showcases his innovative approach to treating immune-related conditions.
Latest Patents
Mark Bodmer holds a patent for "Compositions and methods for treating immune disorders using immune modulating bacteria strains." This patent outlines methods and compositions that are related to immune-modulating strains, which are useful as therapeutic agents. In particular, the patent describes methods for treating an immune disorder in a subject by administering a bacterial composition that includes Strain A (ATCC Deposit Number PTA-125368).
Career Highlights
Bodmer is currently associated with Evelo Biosciences, Inc., where he continues to explore and develop innovative solutions for immune disorders. His work at Evelo has positioned him as a key player in the biotechnology sector, contributing to advancements that could potentially improve patient outcomes.
Collaborations
Mark Bodmer collaborates with talented professionals in his field, including Brian Goodman and Holly Ponichtera. These collaborations enhance the research and development efforts at Evelo Biosciences, fostering an environment of innovation and discovery.
Conclusion
Mark Bodmer's contributions to the field of immune modulation through his patent and work at Evelo Biosciences highlight his commitment to advancing medical science. His innovative approaches have the potential to make a significant impact on the treatment of immune disorders.